Authors:
Vahteristo, P
Syrjakoski, K
Eerola, H
Kainu, T
Holli, K
Blomqvist, C
Kallioniemi, OP
Nevanlinna, H
Citation: P. Vahteristo et al., Re: Population-based study of BRCA1 and BRCA2 mutations in 1035 unselectedFinnish breast cancer patients - Response, J NAT CANC, 93(2), 2001, pp. 153-154
Authors:
Barkardottir, RB
Sarantaus, L
Arason, A
Vehmanen, P
Bendahl, PO
Kainu, T
Syrjakoski, K
Krahe, R
Huusko, P
Pyrhonen, S
Holli, K
Kallioniemi, OP
Egilsson, V
Kere, J
Nevanlinna, H
Citation: Rb. Barkardottir et al., Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families, EUR J HUM G, 9(10), 2001, pp. 773-779
Authors:
Mononen, N
Ikonen, T
Syrjakoski, K
Matikainen, M
Schleutker, J
Tammela, TLJ
Koivisto, PA
Kallioniemi, OP
Citation: N. Mononen et al., A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland, BR J CANC, 84(10), 2001, pp. 1344-1347
Authors:
Rapakko, K
Allinen, M
Syrjakoski, K
Vahteristo, P
Huusko, P
Vahakangas, K
Eerola, H
Kainu, T
Kallioniemi, OP
Nevanlinna, H
Winqvist, R
Citation: K. Rapakko et al., Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites, BR J CANC, 84(1), 2001, pp. 116-119
Authors:
Syrjakoski, K
Vahteristo, P
Eerola, H
Tamminen, A
Kivinummi, K
Sarantaus, L
Holli, K
Blomqvist, C
Kallioniemi, OP
Kainu, T
Nevanlinna, H
Citation: K. Syrjakoski et al., Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients, J NAT CANC, 92(18), 2000, pp. 1529-1531
Authors:
Sarantaus, L
Huusko, P
Eerola, H
Launonen, V
Vehmanen, P
Rapakko, K
Gillanders, E
Syrjakoski, K
Kainu, T
Vahteristo, P
Krahe, R
Paakkonen, K
Hartikainen, J
Blomqvist, C
Lopponen, T
Holli, K
Ryynanen, M
Butzow, R
Borg, A
Arver, BW
Holmberg, E
Mannermaa, A
Kere, J
Kallioniemi, OP
Winqvist, R
Nevanlinna, H
Citation: L. Sarantaus et al., Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland, EUR J HUM G, 8(10), 2000, pp. 757-763
Authors:
Kainu, T
Juo, SHH
Desper, R
Schaffer, AA
Gillanders, E
Rozenblum, E
Freas-Lutz, D
Weaver, D
Stephan, D
Bailey-Wilson, J
Kallioniemi, OP
Tirkkonen, M
Syrjakoski, K
Kuukasjarvi, T
Koivisto, P
Karhu, R
Holli, K
Arason, A
Johannesdottir, G
Bergthorsson, JT
Johannsdottir, H
Egilsson, V
Barkardottir, RB
Johannsson, O
Haraldsson, K
Sandberg, T
Holmberg, E
Gronberg, H
Olsson, H
Borg, A
Vehmanen, P
Eerola, H
Heikkila, P
Pyrhonen, S
Nevanlinna, H
Citation: T. Kainu et al., Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus, P NAS US, 97(17), 2000, pp. 9603-9608
Authors:
Mononen, N
Syrjakoski, K
Matikainen, M
Tammela, TLJ
Schleutker, J
Kallioniemi, OP
Trapman, J
Koivisto, PA
Citation: N. Mononen et al., Two percent of Finnish prostate cancer patients have a germ-line mutation in the hormone-binding domain of the androgen receptor gene, CANCER RES, 60(22), 2000, pp. 6479-6481